Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance.
Freeman B, Lester S, Mills L, Rasheed MAU, Moye S, Abiona O, Hutchinson GB, Morales-Betoulle M, Krapinunaya I, Gibbons A, Chiang CF, Cannon D, Klena J, Johnson JA, Owen SM, Graham BS, Corbett KS, Thornburg NJ.
Freeman B, et al. Among authors: johnson ja.
bioRxiv [Preprint]. 2020 Apr 25:2020.04.24.057323. doi: 10.1101/2020.04.24.057323.
bioRxiv. 2020.
PMID: 32511332
Free PMC article.
Preprint.